SLC2A1 and Other metabolic disease: This hypometabolism finding is compatible with GLUT-1 expression reduction, a metabolic disorder and/or a vascular-neuronal dysfunction coursing with consequent breakdown of the blood-brain barrier and degeneration [23–24].